AGIOS PHARMACEUTICALS, INC. Investment Income, Net
AGIOS PHARMACEUTICALS, INC. (AGIO) reported Investment Income, Net of $8.25 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-03.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2023-08-03
- AGIOS PHARMACEUTICALS, INC. investment income, net for the quarter ending 2023-06-30 was $8.25M, a 360.35% increase year-over-year.
- AGIOS PHARMACEUTICALS, INC. investment income, net for the quarter ending 2023-03-31 was $8.09M, a 1065.85% increase year-over-year.
- AGIOS PHARMACEUTICALS, INC. investment income, net for the quarter ending 2022-09-30 was $3.82M, a 1391.41% increase year-over-year.
- AGIOS PHARMACEUTICALS, INC. investment income, net for the quarter ending 2022-06-30 was $1.79M.
| Period end | Investment Income, Net 3 month | Investment Income, Net 6 month | Investment Income, Net 9 month |
|---|---|---|---|
| 2023-06-30 | $8.25M 10-Q · filed 2023-08-03 | $16.34M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $8.09M 10-Q · filed 2023-05-04 | ||
| 2022-09-30 | $3.82M 10-Q · filed 2022-11-03 | $5.61M derived: sum of 2 quarters · filed 2023-08-03 | $6.30M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $1.79M 10-Q · filed 2023-08-03 | $2.49M 10-Q · filed 2023-08-03 | |
| 2022-03-31 | $694.00K 10-Q · filed 2023-05-04 | ||
| 2021-09-30 | $256.00K 10-Q · filed 2022-11-03 | $164.00K derived: sum of 2 quarters · filed 2022-11-03 | $504.00K 10-Q · filed 2022-11-03 |
| 2021-06-30 | -$92.00K 10-Q · filed 2022-08-04 | $248.00K 10-Q · filed 2022-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |